Report updated May 23, 2026
Blood Sugar Master-AI Monitor
For individuals seeking basic health tracking tools and AI-assisted health information management.
Blood Sugar Master-AI Monitor is a struggling medical app that is free with in-app purchases. With a 1.0/5 rating from 1 reviews, it struggles with user retention.
What is Blood Sugar Master-AI Monitor?
Blood Sugar Master-AI Monitor is a health-tracking utility for manual logging of glucose, blood pressure, and heart rate on iOS and Android.
Users hire this app to consolidate basic health metrics in one interface, but the current ad-heavy design forces a trade-off between utility and navigation friction.
Current Momentum
v1.8 · 4d ago
Intense- Ships bug fixes and experience improvements.
- Maintains manual-entry utility focus.
Active Nemesis
mySugr - Diabetes Tracker Log
By mySugr
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalRating Pulse 🇺🇸
Recent User Mood
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Manual entry interface for blood sugar, blood pressure, and heart rate metrics
Utility tools for calculating body mass index and daily water intake requirements
IP-based conversational interface for health-related queries
How much does it cost?
- Free tier with core logging
- Premium tier via in-app purchases
Freemium model utilizing in-app purchases to gate advanced chatbot features while maintaining a free utility-based entry point.
Who Built It?
HONG KONG APEX ENERGY TECHNOLOGY CO.
Providing mobile utility and health-tracking tools to help users manage daily digital and wellness tasks. Focused on accessible, multi-functional mobile solutions.
Portfolio
4
Apps
What other apps does HONG KONG APEX ENERGY TECHNOLOGY CO. make?
Explore the full HONG KONG APEX ENERGY TECHNOLOGY CO. report
Portfolio breakdown, audience, momentum, and every app published by HONG KONG APEX ENERGY TECHNOLOGY CO..
What do users think recently?
Low confidence · 1 reviews analyzed
How did the latest release land?
What is the recent mood?
Recent user voice shows a upset sentiment. but report aggressive advertisement frequency interrupts the core user experience during navigation and feature interaction.
Limited review volume (1 reviews). Sentiment analysis will deepen as more data lands.
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for Blood Sugar Master-AI Monitor?
How's The Medical Market?
How does it evolve in the Medical market?
The app shows high volatility in the Medical category, with new entries across multiple regions (e.g., #3 in JO, #4 in NP) but significant rank drops in established markets like the US (#86). This suggests a reliance on initial discovery rather than sustained retention.
Rank progression
40 active rankings tracked — 30-day window
Which niche is Blood Sugar Master-AI Monitor in?
to track and manage daily health metrics
Explore the full Diabetes Management Trackers niche
Every app in this space — 46 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.
The rivals identified
Nemeses(1)
NimbleRx dominates the medical utility space by bridging the gap between health tracking and pharmacy logistics, directly competing for the user's daily health management attention.
Contenders(4)
Gout Diet competes for the same health-conscious demographic by focusing on dietary management and symptom tracking.
This app targets the specific, high-growth market of GLP-1 medication users, overlapping with the target's blood sugar management features.
Health4U is a clinical-grade contender that leverages institutional credibility to provide direct access to medical records.
Cuspart competes by offering a specialized, privacy-focused alternative for users who prioritize offline data logging and professional reporting.
Same space(3)
GotCGM competes by offering high-end ecosystem integration, specifically for users with Continuous Glucose Monitors.
This app is a direct functional peer, offering a similar suite of logging tools for blood glucose and insulin management.
GlucoseWatch is a direct peer that focuses on the wearable ecosystem, specifically targeting Apple Watch users.
Compare Blood Sugar Master-AI Monitor against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for Blood Sugar Master-AI Monitor
Strengths to defend, gaps to attack
Core Strengths
- Broad utility set provides a single-app solution for basic health tracking
Critical Frictions
- 1-star rating baseline
- Aggressive ad-interruption at launch prevents core feature adoption
Growth Levers
- Shift to hardware-agnostic data import to reduce manual entry friction
- Introduce subscription-based ad-removal to stabilize retention
Market Threats
- Medical-grade competitors offer automated data streams that make manual logging apps redundant
What are the next best moves?
Cut launch-interstitial ads because they trigger immediate churn before feature interaction → improve retention baseline
Sentiment analysis identifies launch ads as the #1 complaint theme.
Trade-off: Pause ad-revenue optimization sprint — current churn rate makes ad-inventory value negligible.
Ship Apple Health/Google Fit integration because manual entry is the primary friction point → increase daily active usage
Competitors like mySugr and OneTouch Reveal use automation to dominate the category.
Trade-off: Deprioritize AI chatbot feature updates — chatbot utility is gated behind the broken ad-funnel.
A counter-intuitive read
The app's high volatility in emerging markets is a liability, not a growth signal, as it indicates the app is being churned through by users who find the ad-load unusable.
Feature Gaps vs Competitors
- Automated CGM data import (available in mySugr and Libre)
- Pattern recognition and trend alerts (available in OneTouch Reveal)
Key Takeaways
The app fails to retain users because of intrusive ad-monetization, so the PM must pivot to a subscription model and automate data entry to compete with hardware-integrated rivals.
Where Is It Heading?
Declining
The medical tracking market is consolidating around automated data capture, leaving manual-entry apps like this one increasingly exposed. Without a shift toward hardware integration or a less aggressive monetization model, the app will continue to see high churn in established markets.
Aggressive ad-interruption at launch and feature selection creates a negative perception, which drives the current 1-star rating and prevents long-term retention.
Lack of automated hardware integration leaves the app vulnerable to clinical-grade competitors, accelerating churn as users seek more efficient tracking solutions.